doi:10.3969/j.issn.1673-8640.2023.07.016

Abstract

CLC Number:

R446.1

Figures/Tables 3

References 15

[1]	KRIVTSOV A V, HOSHII T, ARMSTRONG S A. Mixed-lineage leukemia fusions and chromatin in leukemia[J]. Cold Spring Harb Perspect Med, 2017, 7(11):a026658. DOI URL
[2]	MEYER C, BURMEISTER T, GRÖGER D, et al. The MLL recombinome of acute leukemias in 2017[J]. Leukemia, 2018, 32(2):273-284. DOI PMID
[3]	STREHL S, KÖNIG M, MEYER C, et al. Molecular dissection of t(11;17)in acute myeloid leukemia reveals a variety of gene fusions with heterogeneous fusion transcripts and multiple splice variants[J]. Genes Chromosomes Cancer, 2006, 45(11):1041-1049. DOI URL
[4]	弓晓媛, 王迎, 刘兵城, 等. MLL基因重排成人急性髓系白血病的特征和预后分析[J]. 中华血液学杂志, 2018, 39(1):9-14.
[5]	SUZUKAWA K, SHIMIZU S, NEMOTO N, et al. Identification of a chromosomal breakpoint and detection of a novel form of an MLL-AF17 fusion transcript in acute monocytic leukemia with t(11;17)(q23;q21)[J]. Int J Hematol, 2005, 82(1):38-41. PMID
[6]	DE BRAEKELEER E, MEYER C, DOUET-GUILBERT N, et al. Identification of MLL partner genes in 27 patients with acute leukemia from a single cytogenetic laboratory[J]. Mol Oncol, 2011, 5(6):555-563. DOI PMID
[7]	PRASAD R, LESHKOWITZ D, GU Y, et al. Leucine-zipper dimerization motif encoded by the AF17 gene fused to ALL-1(MLL)in acute leukemia[J]. Proc Natl Acad Sci U S A, 1994, 91(17):8107-8111. DOI URL
[8]	CHAPLIN T, AYTON P, BERNARD O A, et al. A novel class of zinc finger/leucine zipper genes identified from the molecular cloning of the t(10;11)translocation in acute leukemia[J]. Blood, 1995, 85(6):1435-1441. DOI URL
[9]	LIN Y M, ONO K, SATOH S, et al. Identification of AF17 as a downstream gene of the beta-catenin/T-cell factor pathway and its involvement in colorectal carcinogenesis[J]. Cancer Res, 2001, 61(17):6345-6349. PMID
[10]	WINTERS A C, BERNT K M. MLL-rearranged leukemias-an update on science and clinical approaches[J]. Front Pediatr, 2017, 5:4. DOI PMID
[11]	LIU H, WESTERGARD T D, CASHEN A, et al. Proteasome inhibitors evoke latent tumor suppression programs in pro-B MLL leukemias through MLL-AF4[J]. Cancer Cell, 2014, 25(4):530-542. DOI PMID
[12]	JO S Y, GRANOWICZ E M, MAILLARD I, et al. Requirement for Dot1l in murine postnatal hematopoiesis and leukemogenesis by MLL translocation[J]. Blood, 2011, 117(18):4759-4768. DOI PMID
[13]	LENARD A, XIE H M, PASTUER T, et al. Epigenetic regulation of protein translation in KMT2A-rearranged AML[J]. Exp Hematol, 2020, 85:57-69. DOI PMID
[14]	CHEN X, WANG F, ZHANG Y, et al. Panoramic view of common fusion genes in a large cohort of Chinese de novo acute myeloid leukemia patients[J]. Leuk Lymphoma, 2019, 60(4):1071-1078. DOI URL
[15]	QIU L, NUNEZ C A, TANG G, et al. A rare case of acute megakaryoblastic leukemia with t(11;17)(q23;q21)and KMT2A:MLLT6 fusion[J]. Ann Hematol, 2022, 101(7):1579-1581. DOI

病例	性别	年龄/岁	AML分型	外周血检测结果
病例	性别	年龄/岁	AML分型	白细胞计数/ （×10⁹/L）	血小板计数/ （×10⁹/L）	血红蛋白/ （g/L）	原始细胞比例/ %
病例1（本病例）	男	43	M5	57.12	78	150.0	69
病例2^[5]	男	40	M5	30.50	82	121.0	54
病例3^[6]	女	45	M5	162.00	83	10.0	97
病例4^[6]	男	19	M5	1.30	152	4.8	4

病例	性别	年龄/岁	AML分型	外周血检测结果
病例	性别	年龄/岁	AML分型	白细胞计数/ （×10⁹/L）	血小板计数/ （×10⁹/L）	血红蛋白/ （g/L）	原始细胞比例/ %
病例1（本病例）	男	43	M5	57.12	78	150.0	69
病例2^[5]	男	40	M5	30.50	82	121.0	54
病例3^[6]	女	45	M5	162.00	83	10.0	97
病例4^[6]	男	19	M5	1.30	152	4.8	4

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 3

References 15

Related Articles 15

Recommended Articles

Metrics

[1]	FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114.
[2]	SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120.
[3]	LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129.
[4]	YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140.
[5]	XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146.
[6]	CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152.
[7]	. [J]. Laboratory Medicine, 2023, 38(12): 1153-1156.
[8]	. [J]. Laboratory Medicine, 2023, 38(12): 1157-1159.
[9]	WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166.
[10]	YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172.
[11]	DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176.
[12]	GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182.
[13]	. [J]. Laboratory Medicine, 2023, 38(12): 1183-1185.
[14]	. [J]. Laboratory Medicine, 2023, 38(12): 1186-1190.
[15]	. [J]. Laboratory Medicine, 2023, 38(12): 1191-1194.